Venus Remedies Limited — Important, 18-12-2024: General Updates

Venus Remedies Limited has addressed a fine imposed by the BSE and NSE for the late submission of unaudited financial results for the quarter ending September 30, 2023, attributed to an inadvertent scanning error that excluded a required profit and loss statement. The aggregate fine amounts to ₹62,540 for BSE and ₹76,700 for NSE, with the payment to BSE already made. The company maintains that this incident will not impact its financial position or operations. Furthermore, Venus Remedies has submitted a waiver request for these fines, but it remains to be seen how NSE will respond. Investors should monitor the situation closely for any future developments regarding the NSE fine and the company's compliance processes.